FGFR4 Inhibitor
Hepatocellular Carcinoma (HCC) & other cancers
Pre-clinicalActive
Key Facts
Indication
Hepatocellular Carcinoma (HCC) & other cancers
Phase
Pre-clinical
Status
Active
Company
About BioArdis
BioArdis is a private, pre-clinical stage biotech company developing novel therapies for oncology, with a unique dual-platform strategy encompassing small molecules and CAR-T cell therapies. Its pipeline includes four pre-clinical small molecule programs and two CAR-T candidates undergoing IND-enabling studies, all aimed at challenging cancer indications, particularly solid tumors. The company is led by a seasoned management team with deep expertise in drug discovery, cell therapy, and operations, positioning it to advance its innovative candidates toward the clinic.
View full company profile